Buy SLU-PP-332 Tablets 500mcg – High-Purity ERR Pan-Agonist for Research

Buy SLU-PP-332 Tablets 500mcg and obtain a precise, research-grade form of this synthetic small-molecule pan-agonist of the estrogen-related receptors ERRα, ERRβ and ERRγ. Each tablet delivers a measured 500 mcg dose in a convenient oral format designed for laboratory use. Research groups studying mitochondrial biogenesis, oxidative metabolism and exercise-related gene programs choose this product for its consistent dosing, third-party verification and reliable documentation.

What Is SLU-PP-332?

SLU-PP-332 is a synthetic small molecule (not a peptide) developed through collaborative work at Saint Louis University. It functions as a pan-agonist at the orphan nuclear receptors ERRα, ERRβ and ERRγ. These receptors regulate transcriptional programs linked to mitochondrial function, fatty-acid oxidation and the molecular signature associated with aerobic exercise adaptation in preclinical models.

In published mouse studies, administration of SLU-PP-332 increased treadmill running endurance, enhanced oxidative muscle fiber characteristics and influenced metabolic parameters without physical training. All available data remain limited to cellular and animal models; no human clinical trials have established safety, efficacy or dosing.

The tablet presentation provides a stable, discrete-dose format that supports accurate experimental design without the need for reconstitution of powder forms.

Key Product Specifications

• Strength: 500 mcg per tablet
• Typical pack size: 50–100 tablets per bottle (supplier dependent)
• Purity: ≥99% (HPLC-verified, batch-specific COA available)
• Form: Oral tablets or capsules
• Molecular formula: C₁₈H₁₄N₂O₂
• Molecular weight: approximately 290 g/mol
• CAS number: 303760-60-3
• Intended use: Laboratory and research use only

Researchers who order SLU-PP-332 500mcg tablets receive material that has undergone analytical testing for identity and purity, supporting reproducible in-vitro and preclinical workflows.

Research Context

SLU-PP-332 activates ERR-mediated transcription, promoting pathways involved in mitochondrial biogenesis and oxidative energy metabolism. Preclinical investigations have examined its effects on endurance capacity, fat oxidation and selected cardiometabolic endpoints in rodent models. A successor compound (SLU-PP-915) was later developed specifically to address oral bioavailability limitations observed with SLU-PP-332.

The compound is supplied strictly as a research chemical. It is not approved for human or veterinary use in any jurisdiction and is not intended for diagnostic, therapeutic or performance applications.

Why Laboratories Choose This Format

When research teams purchase SLU-PP-332 research compound, they prioritise precise microgram dosing, analytical transparency and stable solid-dose presentation. The 500 mcg tablet format eliminates weighing variability associated with bulk powder and simplifies protocol standardisation across multiple experimental arms.

Current professional pricing for COA-backed bottles places the product competitively within the research-chemical market. Volume options are available for groups establishing ongoing SLU-PP-332 professional research supply.

Product Advantages for Research Use

• Accurate 500 mcg dosing per unit
• High-purity, third-party tested material
• Convenient solid oral format
• Full batch traceability via Certificate of Analysis
• Suitable for structured laboratory protocols

Whether you require a single bottle for preliminary assays or prefer SLU-PP-332 tablets wholesale arrangements for larger studies, source exclusively from established research suppliers that provide verified analytical documentation.

Frequently Asked Questions

Is SLU-PP-332 a peptide?
No. It is a synthetic small molecule that acts as a pan-agonist of estrogen-related receptors (ERRα/β/γ).

What is the strength per tablet?
500 mcg of SLU-PP-332 per tablet.

Is a Certificate of Analysis provided?
Yes. Reputable suppliers include batch-specific COAs verifying purity and identity.

Has it been tested in humans?
No published human clinical trials exist. All efficacy and safety data are limited to cellular and animal studies.

What is the intended use?
Laboratory and research use only. Not for human or veterinary consumption.

How should it be stored?
Store in a cool, dry place protected from light, according to the supplier’s instructions.

Secure high-purity research material today. Qualified laboratories ready to investigate ERR-mediated metabolic pathways choose to buy SLU-PP-332 Tablets 500mcg for its verified purity, precise dosing and reliable documentation. Contact your preferred authorised research supplier now to order SLU-PP-332 500mcg tablets and obtain authentic, COA-backed product for your experimental protocols.